Skip to content
SEARCH icon
  • Trade Alerts
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
Search

SEARCH FOR AN ARTICLE

  • Trade Alerts
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
icon

      HomeBiotech

      Biotech

      FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors
      Biotech

      FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors

      March 30, 2025
      FDA Roundup: March 28, 2025
      Biotech

      FDA Roundup: March 28, 2025

      March 29, 2025
      ARTHEx Biotech to Participate in the 24th Annual Needham Virtual Healthcare Conference
      Biotech

      ARTHEx Biotech to Participate in the 24th Annual Needham Virtual Healthcare Conference

      March 28, 2025
      Photocure appoints Jane Healy as Vice President and General Manager EMEA
      Biotech

      Photocure appoints Jane Healy as Vice President and General Manager EMEA

      March 27, 2025
      BioArctic’s partner Eisai presents sales simulation for Leqembi® at its annual press conference
      Biotech

      BioArctic’s partner Eisai presents sales simulation for Leqembi® at its annual press conference

      March 26, 2025
      Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019
      Biotech

      Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019

      March 25, 2025
      Kedrion Expands Ryplazim Distribution Network for PLGD-1 Patients
      Biotech

      Kedrion Expands Ryplazim Distribution Network for PLGD-1 Patients

      March 24, 2025
      TCBP Announces Transition from Nasdaq to OTC Markets
      Biotech

      TCBP Announces Transition from Nasdaq to OTC Markets

      March 23, 2025
      Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
      Biotech

      Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference

      March 22, 2025
      Antengene Announces 2024 Full-Year Financial Results, Proprietary Programs Advancing to Pivotal Trials with Accelerating Multi-market Revenue Ramp Up
      Biotech

      Antengene Announces 2024 Full-Year Financial Results, Proprietary Programs Advancing to Pivotal Trials with Accelerating Multi-market Revenue Ramp Up

      March 21, 2025
      « 1 … 21 22 23 24 25 … 30 »

       

      LATEST NEWS

      • Investing News HSBC Q3 Earnings Overview
      • Investing News Novartis Eyes Major M&A Deals
      • Investing News Wayfair’s Q3 2025 Earnings Overview
      • Investing News UPS Q3 2025 Earnings Report Analysis

      Trending Stock Alerts

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Trending Stock Alerts.

      I want e-mail alerts, updates, and offers and agree to the Trending Stock Alerts privacy policy.

      Market Jar Media Inc. © 2025